Director ZERBE ROBERT L MD Sells Shares of Vericel Corp (VCEL) [Yahoo! Finance]
Vericel Corporation (VCEL)
Last vericel corporation earnings: 2/25 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vcel.com/investor-relations
Company Research
Source: Yahoo! Finance
SEC Filing . The transaction was executed at a price of $44.22 per share, resulting in a total sale amount of $101,706. Warning! GuruFocus has detected 4 Warning Sign with VCEL. Vericel Corp, traded on the NASDAQ under the ticker VCEL, specializes in the development, manufacture, and marketing of cell therapies for patients with serious diseases and conditions. The company's product portfolio includes treatments for cartilage defects in the knee, severe burns, and various other medical conditions. Over the past year, the insider has sold a total of 17,000 shares of Vericel Corp and has not made any purchases of the stock. The recent sale by the insider is part of a trend observed over the last year, where there have been no insider buys and 15 insider sells. Shares of Vericel Corp were trading at $44.22 on the date of the insider's recent transaction, giving the company a market capitalization of $2.112 billion. The stock's price-to-GF-Value ratio stands at 1.06, indicating
Show less
Read more
Impact Snapshot
Event Time:
VCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCEL alerts
High impacting Vericel Corporation news events
Weekly update
A roundup of the hottest topics
VCEL
News
- Here's Why Shareholders May Want To Be Cautious With Increasing Vericel Corporation's (NASDAQ:VCEL) CEO Pay Packet [Yahoo! Finance]Yahoo! Finance
- Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024GlobeNewswire
- Vericel Corporation (NASDAQ:VCEL) On The Verge Of Breaking Even [Yahoo! Finance]Yahoo! Finance
- Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb [Yahoo! Finance]Yahoo! Finance
- Vericel Co. (NASDAQ: VCEL) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $54.00 price target on the stock.MarketBeat
VCEL
Earnings
- 2/29/24 - Beat
VCEL
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- 5/3/24 - Form 4
- VCEL's page on the SEC website